Clinical Study to Study Safety and Efficacy of herbal formulation - Aayudh Advance
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025977
- Lead Sponsor
- Ms Shukla Ashar Impex Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Subject willing to sign informed consent.
Subject age group of 18 years and above of both gender.
All patients with COVID-19 PCR positive (within 7 days/high clinical suspicion admitted to Corona Virus study participating hospital will be eligible.
Patients who are having mild to moderate symptoms of Covid-19 disease and tested positive for Covid-19 test.
Patients younger than 18 years.
Women who are pregnant or who intend to become pregnant for the next three months after taking the drug.
Patients allergic to type medications or any of the ingredient of the formulation.
Patients with a neurological history (seizures, epilepsy, etc.).
Patients with a previous history of psychiatric illnesses (depression, anxiety, suicide attempt).
Patients with cardiac pathologies or relevant chronic diseases that in the judgment of the clinician recommend the non-inclusion of the patient in the study.
Patients who would require artificial ventilation or oxygen supply.
Very severe patients of Covid 19.
Patients with severe hypertension, diabetes shall be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method